The company reported total revenue for the quarter of Rs 5,145 million (mn), representing growth of 33 per cent year-on-year. EBITDA including other income was Rs 1,296 mn and rose seven per cent against the comparable quarter, delivering an EBITDA margin of 25.20 per cent. Profit after tax for the quarter was Rs 606 mn, up 12 per cent year-on-year. For the nine months ended 31 December 2025 the company recorded consolidated revenue of Rs 17,297 mn and EBITDA of Rs 4,024 mn, reflecting sustained expansion across businesses. The management highlighted continued momentum in custom synthesis and speciality products driven by both domestic and global demand. The quarter results contributed to strengthening cash flows and operational metrics for the period. A significant strategic development during the period was the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States. The acquisition is expected to broaden the group’s global footprint, enhance capabilities in advanced custom synthesis and deepen access to regulated markets and innovator customers in North America. Management indicated the move forms an important step in building a global speciality chemical platform. Anupam Rasayan India Limited is engaged in custom synthesis and the manufacture of speciality chemicals with two verticals covering life science related speciality chemicals and other speciality chemicals such as polymer additives. The company supplies a diverse customer base of over 75 domestic and international customers, including 31 multinational companies, and operates six manufacturing facilities in Gujarat with four facilities at Sachin in Surat and two at Jhagadia in Bharuch. Aggregate installed capacity stood at about 30,000 tonne (t) as of 31 March 2025. For further information the investor relations advisor was Ernst & Young LLP and the public relations contact was Sanchi Yadav at the agency specified in the filing. The company stated the press release and financial results have been posted on its website.